> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Cresilon’s Traumagel
- URL: https://www.fdaweb.com/fda-clears-cresilons-traumagel/
- Published: 2024-08-15T12:00:00.000Z
- Updated: 2026-09-14T14:38:27.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5157582

FDA has given 510(k) clearance to Cresilon’s Traumagel for temporary external use to control moderate to severe bleeding. A company [statement](https://cresilon.com/2024/08/15/cresilon-receives-fda-clearance-for-traumagel/?ref=fdaweb.com) says its plant-based hemostatic gel technology is designed to stop and control life-threatening bleeding in seconds when applied to a wound at the point of care. “Traumagel, which utilizes Cresilon’s proprietary hydrogel technology, is a first-of-its-kind hemostatic medical device with FDA clearance for temporary external use in moderate to severe bleeding,” it says.